Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nucleic acid vaccine against the SARS-CoV-2 coronavirus

Nucleic acid vaccine against the SARS-CoV-2 coronavirus

US Patent 12171827 · Granted Dec 24, 2024

Estimated economic value: $168,492,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nucleic acid vaccine against the SARS-CoV-2 coronavirus2025
Nucleic acid vaccine against the SARS-CoV-2 coronavirus2025
Nucleic acid vaccine against the SARS-CoV-2 coronavirus2025
Nucleic acid vaccine against the SARS-CoV-2 coronavirus2024
Nucleic acid vaccine against the SARS-CoV-2 coronavirus2024
Nucleic acid vaccine against the SARS-CoV-2 coronavirus2024
Nucleic acid vaccine against the SARS-CoV-2 coronavirus2024
Nucleic acid vaccine against the SARS-CoV-2 coronavirus2024
Nucleic acid vaccine against the SARS-CoV-2 coronavirus2024
Nucleic acid vaccine against the SARS-CoV-2 coronavirus2024
Nucleic acid vaccine against the SARS-CoV-2 coronavirus2024
Nucleic acid vaccine against the SARS-CoV-2 coronavirus2024